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Abstract The cofactor of several flavoenzymes i autocatalyt- 
ically bound to the polypeptide via a histidyl(N3)-(8ct)-FAD 
linkage which makes the generation of apoenzyme difficult. We 
introduced an alternative covalent protein-FAD bond at the 
active site of 6-hydroxy-D-nicotine oxidase (6HDNO) by 
replacing the FAD-binding histidine with cysteine. The resulting 
mutant enzyme was expressed with noncovalently attached 
cofactor. Incubation with 8-(methylsulfonyl)FAD, and less 
efficiently with 8-chloro-FAD, resulted in the spontaneous 
replacement of the noncovalently bound FAD by the flavin 
derivative and the formation of an 8-(N-acetylcysteinyl)FAD 
linkage. The flavinylated 6HDNO.cys exhibited close to wild- 
type activity levels. This strategy may be generally applicable to 
the attachment of artificially designed flavin derivatives to the 
active site of covalently flavinylated enzymes. 
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I. Introduction 
An increasing number of flavoenzymes with covalently at- 
tached cofactors are being discovered [1]. The most common 
linkage between polypeptide and ravin is a histidyl(N1 or Na)- 
(8a)FAD bond. The bond is formed in an autocatalytic pro- 
cess during the folding of the enzyme inside the cell and once 
formed it is not possible for it to be hydrolyzed without de- 
gradation of the protein. The spontaneous attachment of the 
cofactor to the protein would represent a convenient way of 
introducing tightly bound FAD derivatives at the active centre 
of these enzymes. However, the difficulty in generating apoen- 
zyme hampers this approach. An alternative covalent protein- 
FAD interaction consists of  a cysteinyl-(8tx)FAD bond, as 
realized in monoamine oxidase [2]. The related linkage 8-(N- 
acetylcysteinyl)FAD may form spontaneously between a pro- 
tein cysteine and the highly reactive FAD derivatives 8- 
chloro-FAD [3] and, more efficiently, 8-(methylsulfonyl)FAD 
[4]. A prerequisite for the spontaneous formation of this bond 
is a proper steric position of the cysteinyl SH group with 
respect o the 8-position of the isoalloxazine ring [3]. Likewise, 
a proper steric interaction between histidyl(N3) and 8ct-CH3 
of FAD must be postulated for the autoflavinylation mech- 
anism as demonstrated for 6-hydroxy-D-nicotine oxidase 
(6HDNO) [5]. By replacing the FAD-binding histidine of 
6HDNO with Cys we tested on this model enzyme the pre- 
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diction of a sterically favorable interaction between an amino 
acid side chain in this position and the isoalloxazine ring with 
the aid of 8-(methylsulfonyl)FAD and 8-chloro-FAD. We 
demonstrate that upon incubation with 8-(methylsulfonyl)- 
FAD the noncovalently bound FAD in the mutant 
6HDNO.cys was spontaneously replaced by covalently bound 
8-(N-acetylcysteinyl)FAD. The reconstituted enzyme showed 
enzyme activity close to wild-type levels. By this method it 
should be possible to generally introduce various functional 
ravin derivatives into the active site of His-FAD enzymes. 
2. Material and methods 
2.1. Chemicals 
8-C1-FAD was a kind gift from Dr. Massey, Michigan; all other 
chemicals were commercial products of the highest purity available. 
2.2. Expression and purification of 6HDNO proteins 
The replacement of the FAD-binding His7~ of 6HDNO with Cys by 
site-directed mutagenesis has been described previously [6]. The 6hdno 
wild-type and 6hdno.cys genes were cloned into the expression vector 
p6HEx3 [7] as a translational fusion with an N-terminal extension of 6 
histidine residues. This allowed the one-step urification of the fusion 
proteins from cell extracts of transformed E. coli JM109 cells on a 
nickel chelating Sepharose column [7]. The 6HDNO protein fraction 
eluted from the Ni 2+ affinity column was over 95% pure, as judged 
from SDS-PAGE analysis. 
2.3. Synthesis of FAD derivatives, reconstitution of holoenzyme and 
spectrometry 
8-C1-FAD was transformed into 8-(methylsulfonyl)FAD according 
to [4]. Purified 6HDNO.cys (0.254).3 gg/gl) was incubated with 10 
gM 8-chloro- or 8-(methylsulfonyl)FAD in 40 mM HEPES, pH 7.4, 
0.5 M NaC1, 0.1 M imidazole at room temperature for various times. 
Wild-type, 6HDNO.cys mutant and protein reconstituted with ravin 
derivatives were precipitated with 5% trichloroacetic acid, at 4°C, 
washed with 5% trichloroacetic acid by resuspension and the precipi- 
tate dissolved in 3 M guanidinium hydrochloride, 0.1 M Tris-HCl, pH 
7.4, 3 mM EDTA. Visible spectra were recorded with the aid of a 
Spectrophotometer Ultrospec Plus, Pharmacia LKB (Freiburg, Ger- 
many); ravin fluorescence emission spectra (excitation at 440 nm) 
with a Perkin Elmer Luminescence Spectrometer LS 50B at a scan 
speed of 90 and an excitation and an emission slit with of 5 mm. 
6HDNO activity was determined according to [8]. 
3. Results and discussion 
The mutant protein, overexpressed and purified from E. coli 
cells, exhibits a yellow color and a visible absorption spectrum 
characteristic of a flavoenzyme (Fig. 1, spectrum 1). Treat- 
ment with trichloroacetic acid results in a colorless protein 
precipitate and a yellow supernatant (Fig. 1, compare spectra 
2 and 3) demonstrating that 6HDNO.cys contains the FAD 
noncovalently bound to the protein. A dissociation constant 
Kd for FAD of 1.8× 10 -5 M -1 could be determined from 
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Fig. 1. Visible absorption spectra of 6HDNO.cys and 6HDNO.cys 
covalently modified with 8-(methylsulfonyl)FAD and 8-chloro-FAD. 
4 ml of a 6HDNO.cys solution (0.3 mg/ml) and 4 ml of the same 
6HDNO.cys solution that had been reacted with 8-(methylsulfonyl)- 
FAD or 8-chloro-FAD for 24 h at room temperature, were precipi- 
tated with 5% trichloroacetic a id, the protein pellets washed by re- 
suspension in 5% trichloroacetic acid and dissolved at 1.2 mg 
protein/ml of 3 M guanidinium hydrochloride. Spectra: 1, 
6HDNO.cys at 1.2 mg/ml prior to trichloroacetic a id precipitation; 
2, supernatant of the trichloroacetic acid-precipitated 6HDNO.cys 
sample; 3, guanidinium hydrochloride solubilized 6HDNO.cys pellet 
obtained by trichloroacetic acid precipitation; 4, guanidinium hy- 
drochloride solubilized pellet of 8-chloro-FAD reacted 6HDNO.cys; 
5, guanidinium hydrochloride solubilized pellet of 8-(methylsulfo- 
nyl)FAD reacted 6HDNO.cys protein. 
dialysis against increasing volumes of 20 mM Tris-HC1, pH 
7.4, 100 mM NaCI buffer. 
When the 6HDNO.cys protein was incubated at room tem- 
perature for 24 h in the presence of 10 ~M 8-(methylsulfo- 
nyl)FAD, followed by precipitation with trichloroacetic acid 
the resulting protein pellet remained colored. The trichlorace- 
tic acid washed and guanidinium hydrochloride dissolved pro- 
tein exhibited a visible absorption spectrum typical of 8-(N- 
acetylcysteinyl)FAD [9], with an absorption maximum at 480 
nm (Fig. 1, spectrum 4). From the extinction coefficient of 
e4s0=25 200 M cm -1 for 8-(N-acetylcysteinyl)FAD [9] a molar 
ratio of 1 : 1 of protein and bound FAD was estimated. Thus, 
8-(methylsulfonyl)FAD completely replaced FAD from the 
mutant protein by formation of a covalent protein-FAD ad- 
duct. Incubation under the same conditions of 6HDNO.cys 
with 8-chloro-FAD resulted in a less pronounced spectral shift 
(Fig. 1, spectrum 5). Evaluation of the fluorescence emission 
spectra of the trichloroacetic acid precipitated and guanidi- 
nium hydrochloride dissolved proteins revealed that only 
about 20% of 6HDNO.cys incorporated covalently 8-chloro- 
FAD as compared to the covalent incorporation of 8-(methyl- 
sulfonyl)FAD (Fig. 2). This finding is in agreement with the 
higher reactivity of the methylsulfonyl derivative as compared 
to the chloro substituted FAD [10,11]. 
The specific enzyme activity of the 6HDNO.cys and 
6HDNO 8-(N-acetylcysteinyl)FAD determined during the first 
5 min of the reaction was approx. 80% of that of the wild-type 
protein expressed and purified under the same conditions as 
the mutant protein. It has been demonstrated previously that 
the 6HDNO.cys activity in cell extracts hows saturation ki- 
netics [6]. Similar kinetics were found for the methylsulfonyl- 
FAD substituted 6HDNO.cys (Fig. 3, open and closed cir- 
cles). The linearity of the reaction with 6HDNO.cys and 
6HDNO 8-(N-acetylcysteinyl)FAD was between 0.95 and 
0.96 as compared to a linearity of always 1 for the wild- 
type enzyme. Formation of the histidyl(N3)-(8c0FAD bond 
in the wild-type enzyme is stimulated in the presence of gly- 
cerol 3-phosphate [5]. The spontaneous formation of the cys- 
teinyl-FAD bond in 6HDNO.cys was not significantly stimu- 
lated by glycerol 3-phosphate. However, the compound had a 
marked effect on the linearity of substrate turnover by the 
mutant and methylsulfonyl-FAD reconstituted nzyme, which 
became 0.99-1 (Fig. 3, open and closed triangles). Apparently, 
glycerol 3-phosphate intervened in some stage of the enzyme 
reaction preventing its inhibition. 
The results presented in this communication demonstrate 
on a model flavoenzyme that replacement of the FAD-binding 
histidine by cysteine allows the spontaneous, covalent incor- 
poration of 8ct-substituted FAD at the active site. This strat- 
egy of introducing FAD derivatives into the active site may be 
generally applicable to naturally occurring covalently flavinyl- 
ated enzymes of the histidine-FAD type. The data show that 
the histidine and the cysteine residue introduced into its place 
in the mutant protein are in a proper steric position to interact 
with the 8c~- or 8-position of the isoalloxazine ring of FAD 
giving additional support o the autocatalytic mechanism of 
enzyme flavinylation [5,12-14]. 
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Fig. 2. FAD fluorescence emission spectra of 6HDNO.cys prior to 
and after reaction with 8-(methylsulfonyl)- and 8-chloro-FAD. The 
spectra of trichloracetic a id precipitated and 3 M guanidinium hy- 
drochloride solubilized samples (prepared as described in the legend 
to Fig. 2) were recorded from: 1, 6HDNO.cys; 2, 6HDNO.cys re- 
acted with 8-chloro-FAD; 3, 6HDNO.cys reacted with 8-(methylsul- 
fonyl)FAD. 
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Fig. 3. Enzyme kinetics of unmodified and of 8-(methylsulfonyl)- 
FAD modified 6HDNO.cys. Enzyme activity of unmodified and 
modified 6HDNO.cys was determined without (open and closed cir- 
cles, respectively) or after incubation with 1 mM glycerol 3-phos- 
phate for 30 min at 30°C (open and closed triangles, respectively). 
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